Six House Members Bought SpaceX Stock Days After Its IPO. Five Sit on Committees That Oversee Musk's Business.

SpaceX went public on June 12. Within six days, members of Congress were buying in.

Rep. William Timmons, R-S.C., purchased as much as $100,000 of SpaceX stock three days after the IPO, according to CNBC's review of House financial disclosures. Timmons chairs a House oversight panel on military and foreign affairs and sits on a financial services subcommittee covering artificial intelligence. Both areas sit at the center of Elon Musk's business.

He wasn't alone. CNBC's tally found at least six House members or their immediate families bought between roughly $83,000 and $245,000 in SpaceX shares within six days of the IPO. The list includes Timmons, Rep. John McGuire (R-Va.), Rep. Dan Meuser (R-Pa.), Rep. Gil Cisneros (D-Calif.), Rep. John James (R-Mich.), and Rep. Jared Moskowitz (D-Fla.).

The disclosed ranges break down like this: $50,001 to $100,000 for Timmons; $1,001 to $15,000 each for McGuire, Moskowitz, and Cisneros; and $15,001 to $50,000 each for James and Meuser. House rules require these ranges instead of exact figures, which is its own transparency problem baked into the disclosure system itself, not something these six members invented.

Five of the six sit on committees overseeing defense, satellite communications, AI, or securities markets, according to CNBC. SpaceX depends on federal approvals and pulls in billions of dollars in government contracts, funded by spending bills these same lawmakers help shape.

The count isn't final. House members have 30 to 45 days to report trades. Monday, July 27, was the deadline for disclosing IPO-day purchases; trades made in the six days after the IPO are due by August 2. That means the real number of lawmakers who bought in could still climb.

There is no evidence any of these six lawmakers traded on nonpublic information, broke congressional trading rules, or used their office to benefit SpaceX. The trades are legal. Three of the six were executed by a spouse or child, not the member personally. Some lawmakers say outside financial advisors manage their accounts without their day-to-day input.

That's the honest baseline. Buying stock in a newly public company that your committee happens to regulate is not, by itself, evidence of corruption. Plenty of members likely saw a hot IPO everyone was talking about and wanted in, the same instinct that drives any retail investor chasing a headline stock.

But the appearance problem is real, and it doesn't require proof of wrongdoing to matter. Kedric Payne, ethics director at the nonpartisan Campaign Legal Center, told CNBC that the SpaceX purchases show how congressional stock trading "opens the door to ethical conflicts." Rep. Pramila Jayapal, D-Wash., was blunter: "Members are making decisions, buying and selling as if they're on Wall Street. And they're not doing it in the interest of their constituents. They're doing it in the interest of their pockets."

That's a Democrat criticizing mostly Republican colleagues, but the list itself isn't partisan. Four Republicans and two Democrats bought in. This isn't a one-party problem. It's a Congress problem.

The core complaint from good-government advocates isn't that these six members broke a law. It's that current law lets any member of Congress buy stock in a company their committee oversees, then wait up to 45 days to tell the public. There's no ban on lawmakers trading individual stocks tied to their oversight portfolios, only a disclosure requirement after the fact.

Multiple bills to ban congressional stock trading entirely have been introduced in recent years, with bipartisan sponsors on both sides of the aisle. None have passed. The SpaceX buying spree gives that effort fresh ammunition, because it's a textbook case: a hot IPO, sitting committee chairs and members with direct oversight of the company's core business lines, and a paper trail showing money moved almost immediately.

Whether Congress does anything about it before the next headline-grabbing IPO, OpenAI or Anthropic are both mentioned by CNBC as possibilities on the horizon, is an open question. The disclosure deadlines built into the current system mean the public won't even know the full scope of who bought SpaceX stock until August 2, nearly two months after the company went public.